Wordt geladen...
Biomarkers in oncology drug development
Biomarker measurements have become an essential component of oncology drug development, particularly so in this era of targeted therapies. Such measurements ensure that clinical studies are testing our biological hypotheses and can help make the difficult decisions required to choose which drugs to...
Bewaard in:
| Gepubliceerd in: | Mol Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527864/ https://ncbi.nlm.nih.gov/pubmed/19383364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.12.002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|